Charles Theuer
Directeur Général chez TRACON PHARMACEUTICALS, INC.
Fortune : 803 641 $ au 30/04/2024
Postes actifs de Charles Theuer
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| TRACON PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/07/2006 | - |
| Directeur Général | 02/08/2006 | - | |
| Investor Relations Contact | 01/07/2006 | - | |
| President | 02/08/2006 | - | |
| Comptroller/Controller/Auditor | 15/06/2018 | 18/09/2019 | |
| Directeur Financier/CFO | 15/06/2018 | 29/01/2021 | |
| 4D MOLECULAR THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/01/2016 | - |
| Independent Dir/Board Member | 01/01/2016 | - | |
| ONCTERNAL THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/05/2018 | - |
| Independent Dir/Board Member | 01/05/2018 | - |
Historique de carrière de Charles Theuer
Anciens postes connus de Charles Theuer
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
TargeGen, Inc.
 TargeGen, Inc. Pharmaceuticals: MajorHealth Technology TargeGen, Inc. manufactures vascular biopharmaceutical products. The company was founded by David A. Cheresh and Peter G. Ulrich in 2001 and is headquartered in San Diego, CA. | Directeur Technique/Scientifique/R&D | 01/01/2004 | 01/01/2006 |
| PFIZER, INC. | Corporate Officer/Principal | 01/01/2003 | 01/01/2004 |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | 01/01/1991 | 01/01/1993 |
| University of California, Irvine | Corporate Officer/Principal | - | - |
Formation de Charles Theuer
| The University of California, San Francisco | Doctorate Degree |
| University of California, Irvine | Doctorate Degree |
| Massachusetts Institute of Technology | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 10 |
Opérationnelle
| Director/Board Member | 3 |
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 2 |
Sectorielle
| Health Technology | 6 |
| Consumer Services | 3 |
| Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| TRACON PHARMACEUTICALS, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| 4D MOLECULAR THERAPEUTICS, INC. | Health Technology |
| ONCTERNAL THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
TargeGen, Inc.
TargeGen, Inc. Pharmaceuticals: MajorHealth Technology TargeGen, Inc. manufactures vascular biopharmaceutical products. The company was founded by David A. Cheresh and Peter G. Ulrich in 2001 and is headquartered in San Diego, CA. | Health Technology |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
- Bourse
- Insiders
- Charles Theuer
- Expérience